7 Best Nano Cap Stocks To Invest In

4. Kyverna Therapeutics, Inc. (NASDAQ:KYTX)

Market Cap: $242.05 Million

Number of Hedge Funds: 17

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) is a clinical-stage biopharmaceutical company that focuses on developing cell therapies for autoimmune diseases. KYV-101 is one of the leading therapies of the company, which is made from patients’ T-cells to target and eliminate harmful cells in the body. The company is involved in various clinical trials to test the safety and effectiveness of its therapies.

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) is making significant strides in developing its lead product candidate, KYV-101, a CAR T-cell therapy aimed at treating autoimmune diseases. CEO, Peter Maag mentioned that the company demonstrated promising initial safety and efficacy results for KYV-101, which targets B cells using a fully human CAR designed to enhance tolerability.

During the second quarter of 2024, the company presented data from 50 patients with 15 different autoimmune conditions, showing that KYV-101 effectively depletes B cells without severe side effects. Moreover, it also received two Regenerative Medicine Advanced Therapy (RMAT) designations from the FDA for KYV-101, specifically for treating Stiff-Person Syndrome and myasthenia gravis.

The company ended the second quarter with cash reserves of $346.2 million and is actively recruiting patients for ongoing trials and plans to share more clinical data throughout 2024. It is one of the best nano cap stocks to invest in as it was held by 17 hedge funds in Q2 2024 as per Insider Monkey’s data.